InsidersTradesSigma
Follow the PCI Biotech Holding ASA share price and the full insider trade history of the company, a listed equity based in Norway. Shares are quoted on the NO market, under the oversight of Oslo Børs. Operating in the Health Care sector, PCI Biotech Holding ASA has recorded 7 public disclosures. Market capitalisation: €2.6m. The latest transaction was reported on 10 January 2025 (Sale). Among the most active insiders: PCI Biotech. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
PCI Biotech Holding ASA is a Norwegian biopharmaceutical company focused on developing innovative treatments for cancer. It utilizes phototherapy technology to enhance the efficacy of anticancer drugs.